Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care.

about

Role of Emerging Insulin Technologies in the Initiation and Intensification of Insulin Therapy for Diabetes in Primary Care.

Item

http://www.wikidata.org/entity/Q36467597

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Role of Emerging Insulin Techn ...... for Diabetes in Primary Care.

@ast

Role of Emerging Insulin Techn ...... for Diabetes in Primary Care.

@en

type

Item

label

Role of Emerging Insulin Techn ...... for Diabetes in Primary Care.

@ast

Role of Emerging Insulin Techn ...... for Diabetes in Primary Care.

@en

prefLabel

Role of Emerging Insulin Techn ...... for Diabetes in Primary Care.

@ast

Role of Emerging Insulin Techn ...... for Diabetes in Primary Care.

@en

P1476

Role of Emerging Insulin Techn ...... for Diabetes in Primary Care.

@en

P2093

Davida F Kruger

http://www.w3.org/2001/XMLSchema#string

Martha M Funnell

http://www.w3.org/2001/XMLSchema#string

Stephen A Brunton

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Use of behavioral change techniques in web-based self-management programs for type 2 diabetes patients: systematic review

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes

Hyperglycemia and microvascular and macrovascular disease in diabetes

Coverage of prandial insulin requirements by means of an ultra-rapid-acting inhaled insulin.

Incretin-based therapies: review of current clinical trial data.

Barriers to insulin initiation: the translating research into action for diabetes insulin starts project.

Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority tria

Clinical characteristics of patients with type 2 diabetes mellitus at the time of insulin initiation: INSTIGATE observational study in Spain.

P304

34-43

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIACLIN.34.1.34

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26807007

http://www.w3.org/2001/XMLSchema#string

P932

4714724

http://www.w3.org/2001/XMLSchema#string